Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T19:57:20.565Z.
Calculation as of: 2026-10-06T19:57:20.565Z.
Quote observation: 2026-10-06T19:55:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49c5230cca2432c6fd0637270100fe2f3d02ebc9238e4fdbb1f4ddcca099658b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-08-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
iSpecimen Inc.
Market Cap
$2.69M
Price/OCF Ratio
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO |
|---|---|---|
| iSpecimen Inc. (ISPC) | $2.69M | N/A |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.70M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.53M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $2.93M | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.41M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.42M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.01M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.39M | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2021-08-10 | 3804.22 |
| 2021-08-09 | 3864.23 |
| 2021-08-06 | 3621.21 |
| 2021-08-05 | 3516.21 |
| 2021-08-04 | 3420.20 |
| 2021-08-03 | 3690.22 |
| 2021-08-02 | 3750.22 |
| 2021-07-30 | 3768.22 |
| 2021-07-29 | 3732.22 |
| 2021-07-28 | 3458.00 |
| 2021-07-27 | 3195.19 |
| 2021-07-26 | 3255.19 |
| 2021-07-23 | 3126.18 |
| 2021-07-22 | 3402.20 |
| 2021-07-21 | 3426.20 |
| 2021-07-20 | 3180.19 |
| 2021-07-19 | 3144.18 |
| 2021-07-16 | 3222.19 |
| 2021-07-15 | 3540.21 |
| 2021-07-14 | 3822.22 |
| 2021-07-13 | 3966.23 |
| 2021-07-12 | 3870.23 |
| 2021-07-09 | 3882.23 |
| 2021-07-08 | 3804.22 |
| 2021-07-07 | 4020.24 |
| 2021-07-06 | 3720.22 |
| 2021-07-02 | 3954.23 |
| 2021-07-01 | 4248.25 |
| 2021-06-30 | 4332.25 |
| 2021-06-29 | 4992.29 |
| 2021-06-28 | 4848.28 |
| 2021-06-25 | 3858.23 |
| 2021-06-24 | 3786.22 |
| 2021-06-23 | 3954.23 |
| 2021-06-22 | 4284.25 |
| 2021-06-21 | 4344.25 |
| 2021-06-18 | 4494.26 |
| 2021-06-17 | 4290.25 |
